The group's principle activities include discovering, developing, manufacturing and distributing clinical diagnostic and research products for use in the fields of coagulation, fibrinolysis, thrombosis, hemostasis and oncology. The group's products include ADAMTS13, IMUCLONE(TM), Tissue Factor, ACTICLOT(R) LA Complete(TM) and DIMERTEST(R). The group operates from United States.
